当前位置: 首页 > 期刊 > 《中国当代医药》 > 2014年第34期 > 正文
编号:12706358
趋化因子受体CXCR2在结直肠癌组织中的表达及其临床意义(4)
http://www.100md.com 2014年12月5日 郑正荣 叶凯 孙亚锋 赵清泉 许建华
第1页

    参见附件。

     [15] Wu H,Xu P,He Y,et al.Evaluation of the rationality of current T staging of gastric cancer with transverse mesocolon invasion[J].Zhonghua Zhong Liu Za Zhi,2014,36(1):43-47.

    [16] Xu Y,Liu B,Shi QL,et al.Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung[J].Int J Clin Exp Med,2014,7(8):2120-2128.

    [17] Li LF,Wei ZJ,Sun H,et al.Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer:a meta-analysis[J].World J Gastroenterol,2014,20(34):12313-12321.

    [18] Feng ST,Luo Y,Chan T,et al.CT evaluation of gastroenteric neuroendocrine tumors:relationship between ct features and the pathologic classification[J].AJR Am J Roentgenol,2014,203(3):W260-266.

    [19] Rathod PS,Shakuntala PN,Pallavi VR,et al.The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer[J].Indian J Surg Oncol,2014,5(2):109-114.

    [20] Peng Y,Li C,Luo DC,et al.Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma[J].Molecules,2014,19(8):11586-11599.

    (收稿日期:2014-10-14 本文编辑:郭静娟)

您现在查看是摘要介绍页,详见PDF附件